Please enable Javascript
Kai-Keen Shiu, MD, PhD
Kai-Keen Shiu, MD, PhD
Articles by Kai-Keen Shiu, MD, PhD
TMD as a Prospective Biomarker for Patients With CRC
Kai-Keen Shiu, MD, PhD
Colorectal Cancer
|
March 13, 2025
Kai-Keen Shiu, MD, PhD, continues his discussion on neoadjuvant pembrolizumab for patients with colorectal cancer.
View More
Neoadjuvant Pembrolizumab Shows Potential Benefits in Early-Stage dMMR/MSI-High CRC
Kai-Keen Shiu, MD, PhD
Colorectal Cancer
|
March 13, 2025
Dr. Shiu also discusses how the NEOPRISM-CRC study exceeded its primary endpoint with a high pCR rate.
View More